patritumab,ruxolitinib
novartis,amgen,daiichi sankyo,incyte
['mbc', 'rux,(-crux),(-trux)', 'patritumab']
her3 . patritumab deruxtecan. new adc for mbc #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists